Written by Eric Sugalski

When developing a new medical product, have you ever heard a medtech investor or exec say, "Take your time. We'll get there when we get there.."?

Me neither.

There's...

Most companies avoid primary market research. They believe that in-house tribal knowledge is enough to make the key product and business decisions. Research would just tell the team...

The prospect of obtaining a new reimbursement code and corresponding coverage for a new medical device is daunting. So much so that many investors simply refuse to pursue medical device...

Hey - Eric here.

Happy Wednesday to 602 motivated medtech business leaders.

Here's one short tip on how to refine your medtech strategy.

Today's Medtech Mindset issue takes about 4...

Hey – Eric here.

Here are 4 steps on how to clearly define the clinical outcome that compels adoption of your new medical device.

Today’s issue of Medtech Mindset takes about 3 minutes...

Consider a medical device startup, facing a critical market decision:

Should the company go big, aiming for the $1B market out of the gate? Or should the company go small, proving value with an...

Written by Eric Sugalski and Ulrich Herken

True story.

A medical device manufacturer developed an at-home wearable defibrillator for populations at high risk of sudden cardiac death. This device...

Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation...

Written by Eric Sugalski

It’s a critical decision that defines your commercial strategy – but it’s one that is often taken without carefully weighing the pros and cons of each...

New technology is one of the primary drivers of growth in the medical device industry. Developing new tech can be long, iterative, and expensive -- so it is understandable that...

Written by Eric Sugalski and Ulrich Herken

“You need to show clinical evidence that your medical device provides a benefit.”

It's a common request that early medical...

Written by Eric Sugalski

Many medtech leaders are pressured by investors and others to rapidly achieve regulatory clearance with a product design that is not intended for the market. This...